Clinton pilots subsidised malaria drugs in Africa

Former U.S. President Bill Clinton is launching a programme to make subsidised malaria drugs available in Tanzania in a test scheme that could serve as a blueprint for Africa as a whole.

The project, to be announced later on Sunday in Dar es Salaam, will make life-saving ACT drugs available at 90 percent less than the current market price to a national drug wholesaler, which will then distribute them to rural shops.

Malaria, caused by a parasite carried by mosquitoes, kills up to 3 million people a year worldwide and makes 300 million seriously ill. Ninety percent of deaths are in Africa south of the Sahara, mostly among young children.

Many of those lives could be saved with modern artemisinin combination therapy (ACT) drugs, which are far more effective than older treatments such as chloroquine. But a price of up to $8 to $10 per treatment puts them out of reach for many people.

Although drugmakers including Novartis and Sanofi-Aventis SA have reduced the cost of ACT medicines to around $1 when they are used in the public sector, the majority of Africans buy their medicine privately.

In the case of Tanzania, around half of patients with malaria seek treatment through private drug shops instead of public health facilities, and most are unable to afford ACTs. Instead, they usually buy older drugs that are 20 to 30 times cheaper but are often ineffective due to drug resistance.

The pilot programme by the Clinton Foundation HIV/AIDS Initiative is designed to test the practicality of subsidising ACT drugs as a way to increase their use, a foundation spokesman said.

ACT treatments are derived from a medicinal Chinese plant and are costly to manufacture.

International organisations and governments, including those form the Netherlands and Britain, are currently considering a multimillion-dollar global subsidy plan for ACT medicines.

Awa Marie Coll-Seck, executive director of the U.N.-backed Roll Back Malaria Partnership, told reporters in London earlier this year she hoped a $300 million global scheme could be introduced as early as 2008.

Clinton, who is on a four-nation African tour of South Africa, Malawi, Zambia and Tanzania, met Zambian President Levy Mwanawasa on Saturday.

He said his foundation would provide support for skills training for medical personnel in that country to honour Zambia for its impressive AIDS fight.

The former U.S president said his Clinton Foundation and UNITAIDS, a global anti-AIDS group, had agreed a deal with pharmaceutical firms to reduce prices of anti-retroviral drugs (ARVs) for poorer nations.

Prices of ARVs for poor nations will be in the region of $25 to $60 per person per year from about $200 per annually.

In Malawi, Clinton inspected a $70 million modern 80-bed hospital under construction in Neno, one the country's poorest districts 75 miles south of the commercial city of Blantyre.

The hospital will completed in March next year and Clinton promised to officially open it.